skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Long-term morbidity after infradiaphragmatic radiotherapy in young men with testicular cancer

Journal Article · · Cancer (Philadelphia); (United States)

Long-term morbidity was evaluated in 357 patients with testicular cancer who were treated by infradiaphragmatic radiotherapy between 1970 and 1982. Myelopathy developed in four patients, radiation osteomyelitis in one, and radiation hepatitis in another after treatment. Posttreatment gastrointestinal symptoms were recorded in the medical records of 4% of patients but were mentioned by 41% of 199 who answered a questionnaire. The moderate gastrointestinal problems were recorded by 17% of the patients compared with 6% in a control group of healthy men. Postirradiation peptic ulcer occurred in 9%. A dose relationship existed, the risk of posttreatment gastrointestinal problems being less when the midplane dose was less than 40 Gy. Forty-one of 63 men who wished to do so fathered at least one child after their radiotherapy. The overall posttreatment quality of life was comparable to that of the control group. The authors conclude that the risk of major posttreatment morbidity is minimal for testicular cancer patients who undergo infradiaphragmatic radiotherapy after orchiectomy. Slight gastrointestinal symptoms are relatively common without major impact on quality of life. Gonadal toxicity is not a significant complication. Infradiaphragmatic radiotherapy is a safe, routine adjuvant treatment of seminoma in orchiectomized patients with Stage I seminoma. The midplane dose should not exceed 36 Gy in these patients.

Research Organization:
Norwegian Radium Hospital, Oslo
OSTI ID:
5596842
Journal Information:
Cancer (Philadelphia); (United States), Vol. 64:2
Country of Publication:
United States
Language:
English

Similar Records

Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients
Journal Article · Wed Feb 01 00:00:00 EST 1989 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5596842

Is Radiotherapy a Good Adjuvant Strategy for Men With a History of Cryptorchism and Stage I Seminoma?
Journal Article · Fri Jan 15 00:00:00 EST 2010 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:5596842

ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer
Journal Article · Thu Jun 01 00:00:00 EDT 2017 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:5596842